318 related articles for article (PubMed ID: 19020387)
1. Measurements of quality of life in patients with growth hormone deficiency.
Webb SM
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):52-5. PubMed ID: 19020387
[TBL] [Abstract][Full Text] [Related]
2. Three-years of growth hormone (GH) replacement therapy in GH-deficient adults: effects on quality of life, patient-reported outcomes and healthcare consumption.
Svensson J; Mattsson A; Rosén T; Wirén L; Johannsson G; Bengtsson BA; Koltowska Häggström M;
Growth Horm IGF Res; 2004 Jun; 14(3):207-15. PubMed ID: 15125882
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and retrospective perception of the effect of growth hormone treatment in adult patients with childhood growth hormone deficiency.
Lagrou K; Xhrouet-Heinrichs D; Massa G; Vandeweghe M; Bourguignon JP; De Schepper J; de Zegher F; Ernould C; Heinrichs C; Malvaux P; Craen M
J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1249-60; discussion 1261-2. PubMed ID: 11964020
[TBL] [Abstract][Full Text] [Related]
4. Long-term improvement of quality of life during growth hormone (GH) replacement therapy in adults with GH deficiency, as measured by questions on life satisfaction-hypopituitarism (QLS-H).
Rosilio M; Blum WF; Edwards DJ; Shavrikova EP; Valle D; Lamberts SW; Erfurth EM; Webb SM; Ross RJ; Chihara K; Henrich G; Herschbach P; Attanasio AF
J Clin Endocrinol Metab; 2004 Apr; 89(4):1684-93. PubMed ID: 15070931
[TBL] [Abstract][Full Text] [Related]
5. Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database.
Abs R; Mattsson AF; Bengtsson BA; Feldt-Rasmussen U; Góth MI; Koltowska-Häggström M; Monson JP; Verhelst J; Wilton P;
Growth Horm IGF Res; 2005 Oct; 15(5):349-59. PubMed ID: 16168692
[TBL] [Abstract][Full Text] [Related]
6. Influences on quality of life in GH deficient adults and their effect on response to treatment.
Murray RD; Skillicorn CJ; Howell SJ; Lissett CA; Rahim A; Smethurst LE; Shalet SM
Clin Endocrinol (Oxf); 1999 Nov; 51(5):565-73. PubMed ID: 10594517
[TBL] [Abstract][Full Text] [Related]
7. The use of self-rating questionnaires as a quantitative measure of quality of life in adult growth hormone deficiency.
Murray RD; Shalet SM
J Endocrinol Invest; 1999; 22(5 Suppl):118-26. PubMed ID: 10442581
[TBL] [Abstract][Full Text] [Related]
8. Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan's syndrome.
Tanriverdi F; Unluhizarci K; Kula M; Guven M; Bayram F; Kelestimur F
Growth Horm IGF Res; 2005 Jun; 15(3):231-7. PubMed ID: 15921942
[TBL] [Abstract][Full Text] [Related]
9. The influence of growth hormone (GH) deficiency and GH replacement on quality of life in GH-deficient patients.
Deijen JB; van der Veen EA
J Endocrinol Invest; 1999; 22(5 Suppl):127-36. PubMed ID: 10442582
[TBL] [Abstract][Full Text] [Related]
10. Growth hormone deficient patients after traumatic brain injury--baseline characteristics and benefits after growth hormone replacement--an analysis of the German KIMS database.
Kreitschmann-Andermahr I; Poll EM; Reineke A; Gilsbach JM; Brabant G; Buchfelder M; Fassbender W; Faust M; Kann PH; Wallaschofski H
Growth Horm IGF Res; 2008 Dec; 18(6):472-8. PubMed ID: 18829359
[TBL] [Abstract][Full Text] [Related]
11. Differential effect sizes of growth hormone replacement on Quality of Life, well-being and health status in growth hormone deficient patients: a meta-analysis.
Deijen JB; Arwert LI; Witlox J; Drent ML
Health Qual Life Outcomes; 2005 Oct; 3():63. PubMed ID: 16236167
[TBL] [Abstract][Full Text] [Related]
12. Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy.
Peker Y; Svensson J; Hedner J; Grote L; Johannsson G
Clin Endocrinol (Oxf); 2006 Jul; 65(1):98-105. PubMed ID: 16817827
[TBL] [Abstract][Full Text] [Related]
13. The "quality of life-assessment of growth hormone deficiency in adults" questionnaire: can it be used to assess quality of life in hypopituitarism?
Barkan AL
J Clin Endocrinol Metab; 2001 May; 86(5):1905-7. PubMed ID: 11344182
[TBL] [Abstract][Full Text] [Related]
14. Hypopituitary control and complications study (HypoCCS): a decade of an outcomes assessment observational study.
Lamberts SW
J Endocrinol Invest; 2008 Sep; 31(9 Suppl):2-5. PubMed ID: 19020377
[TBL] [Abstract][Full Text] [Related]
15. Validation of the Japanese version of the Quality of Life-Assessment of Growth Hormone Deficiency in Adults (QoL-AGHDA).
Suzukamo Y; Noguchi H; Takahashi N; Shimatsu A; Chihara K; Green J; Fukuhara S
Growth Horm IGF Res; 2006; 16(5-6):340-7. PubMed ID: 17081792
[TBL] [Abstract][Full Text] [Related]
16. Quality of life in congenital, untreated, lifetime isolated growth hormone deficiency.
Barbosa JA; Salvatori R; Oliveira CR; Pereira RM; Farias CT; Britto AV; Farias NT; Blackford A; Aguiar-Oliveira MH
Psychoneuroendocrinology; 2009 Jul; 34(6):894-900. PubMed ID: 19181452
[TBL] [Abstract][Full Text] [Related]
17. Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiency.
Kołtowska-Haggstrom M; Hennessy S; Mattsson AF; Monson JP; Kind P
Horm Res; 2005; 64(1):46-54. PubMed ID: 16103683
[TBL] [Abstract][Full Text] [Related]
18. Ten-year change in quality of life in adults on growth hormone replacement for growth hormone deficiency: an analysis of the hypopituitary control and complications study.
Mo D; Blum WF; Rosilio M; Webb SM; Qi R; Strasburger CJ
J Clin Endocrinol Metab; 2014 Dec; 99(12):4581-8. PubMed ID: 25233155
[TBL] [Abstract][Full Text] [Related]
19. Seven years of growth hormone (GH) replacement improves quality of life in hypopituitary patients with adult-onset GH deficiency.
Elbornsson M; Horvath A; Götherström G; Bengtsson BÅ; Johannsson G; Svensson J
Eur J Endocrinol; 2017 Feb; 176(2):99-109. PubMed ID: 27803031
[TBL] [Abstract][Full Text] [Related]
20. Prediction of improvement in quality of life (QoL-AGHDA) in adults with growth hormone deficiency by normative reference limits: data of the German KIMS cohort.
Moock J; Friedrich N; Völzke H; Spielhagen C; Nauck M; Koltowska-Häggström M; Buchfelder M; Wallaschofski H; Kohlmann T
Growth Horm IGF Res; 2011 Oct; 21(5):272-8. PubMed ID: 21865066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]